Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419144.RAR8h4Pg8R0ceXXuBD4j0AlAdao2AT_ZM5u1XBXF2_02c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419144.RAR8h4Pg8R0ceXXuBD4j0AlAdao2AT_ZM5u1XBXF2_02c130_assertion type Assertion NP419144.RAR8h4Pg8R0ceXXuBD4j0AlAdao2AT_ZM5u1XBXF2_02c130_head.
- NP419144.RAR8h4Pg8R0ceXXuBD4j0AlAdao2AT_ZM5u1XBXF2_02c130_assertion description "[In parallel, data obtained in a primary breast cancer clinical series showed that disease-free survival was shorter in individuals bearing the CCR5Delta32 allele than in CCR5 wild-type patients, but only for those whose tumors expressed wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419144.RAR8h4Pg8R0ceXXuBD4j0AlAdao2AT_ZM5u1XBXF2_02c130_provenance.
- NP419144.RAR8h4Pg8R0ceXXuBD4j0AlAdao2AT_ZM5u1XBXF2_02c130_assertion evidence source_evidence_literature NP419144.RAR8h4Pg8R0ceXXuBD4j0AlAdao2AT_ZM5u1XBXF2_02c130_provenance.
- NP419144.RAR8h4Pg8R0ceXXuBD4j0AlAdao2AT_ZM5u1XBXF2_02c130_assertion SIO_000772 14597737 NP419144.RAR8h4Pg8R0ceXXuBD4j0AlAdao2AT_ZM5u1XBXF2_02c130_provenance.
- NP419144.RAR8h4Pg8R0ceXXuBD4j0AlAdao2AT_ZM5u1XBXF2_02c130_assertion wasDerivedFrom befree-2016 NP419144.RAR8h4Pg8R0ceXXuBD4j0AlAdao2AT_ZM5u1XBXF2_02c130_provenance.
- NP419144.RAR8h4Pg8R0ceXXuBD4j0AlAdao2AT_ZM5u1XBXF2_02c130_assertion wasGeneratedBy ECO_0000203 NP419144.RAR8h4Pg8R0ceXXuBD4j0AlAdao2AT_ZM5u1XBXF2_02c130_provenance.